These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10634264)

  • 1. Donepezil for Huntington's disease.
    Fernandez HH; Friedman JH; Grace J; Beason-Hazen S
    Mov Disord; 2000 Jan; 15(1):173-6. PubMed ID: 10634264
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility of vascular dementia treatment with cholinesterase inhibitors.
    Li Y; Meyer JS; Haque MA; Chowdhury MH; Hinh P; Quach M
    Int J Geriatr Psychiatry; 2002 Feb; 17(2):194-6. PubMed ID: 11813286
    [No Abstract]   [Full Text] [Related]  

  • 3. Open-label study of donepezil in chronic poststroke aphasia.
    Berthier ML; Hinojosa J; Martín Mdel C; Fernández I
    Neurology; 2003 Apr; 60(7):1218-9. PubMed ID: 12682346
    [No Abstract]   [Full Text] [Related]  

  • 4. Donepezil use in the treatment of dementia associated with Down syndrome.
    Cipriani G; Bianchetti A; Trabucchi M
    Arch Neurol; 2003 Feb; 60(2):292; author reply 292. PubMed ID: 12580720
    [No Abstract]   [Full Text] [Related]  

  • 5. Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report.
    Miyaoka T; Seno H; Yamamori C; Inagaki T; Itoga M; Tsubouchi K; Horiguchi J
    J Clin Psychiatry; 2001 Jul; 62(7):573-4. PubMed ID: 11488374
    [No Abstract]   [Full Text] [Related]  

  • 6. An open-label trial of donepezil (aricept) in the treatment of persons with mild traumatic brain injury.
    Kaye NS; Townsend JB; Ivins R
    J Neuropsychiatry Clin Neurosci; 2003; 15(3):383-4; author reply 384-5. PubMed ID: 12928519
    [No Abstract]   [Full Text] [Related]  

  • 7. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
    Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil for nursing home patients with dementia: a reinterpretation of the evidence.
    Steinman MA; Covinsky KE
    J Am Geriatr Soc; 2003 Jan; 51(1):132; author reply 132-3. PubMed ID: 12534859
    [No Abstract]   [Full Text] [Related]  

  • 9. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
    Prasher VP; Adams C; Holder R;
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic malignant-like syndrome due to donepezil and maprotiline.
    Ohkoshi N; Satoh D; Nishi M; Shoji S
    Neurology; 2003 Mar; 60(6):1050-1. PubMed ID: 12654986
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral complications associated with donepezil.
    Wengel SP; Roccaforte WH; Burke WJ; Bayer BL; McNeilly DP; Knop D
    Am J Psychiatry; 1998 Nov; 155(11):1632-3. PubMed ID: 9812142
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome induced by donepezil.
    Matsumoto T; Kawanishi C; Isojima D; Iseki E; Kishida I; Kosaka K
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):101-3. PubMed ID: 14731314
    [No Abstract]   [Full Text] [Related]  

  • 13. Questions about donepezil.
    Elie LM; Cole MG
    CMAJ; 1998 Apr; 158(8):1014-5. PubMed ID: 9580729
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal movements with donepezil in Alzheimer disease.
    Amouyal-Barkate K; Bagheri-Charabiani H; Montastruc JL; Moulias S; Vellas B
    Ann Pharmacother; 2000 Nov; 34(11):1347. PubMed ID: 11098352
    [No Abstract]   [Full Text] [Related]  

  • 15. Donepezil for severe Alzheimer's disease.
    Opie LH
    Lancet; 2006 Jul; 368(9533):361-2; author reply 362. PubMed ID: 16876651
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia.
    Hegerl U; Mergl R; Henkel V; Gallinat J; Kotter G; Müller-Siecheneder F; Pogarell O; Juckel G; Schröter A; Bahra R; Emir B; Laux G; Möller HJ
    J Clin Psychopharmacol; 2003 Apr; 23(2):214-6. PubMed ID: 12640228
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
    Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J
    Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Donepezil as treatment of Charles Bonnet syndrome].
    Santos-Bueso E; Serrador-García M; García-Sánchez J
    Arch Soc Esp Oftalmol; 2013 Sep; 88(9):369-70. PubMed ID: 23988046
    [No Abstract]   [Full Text] [Related]  

  • 19. Violent behavior-associated with donepezil.
    Bouman WP; Pinner G
    Am J Psychiatry; 1998 Nov; 155(11):1626-7. PubMed ID: 9812132
    [No Abstract]   [Full Text] [Related]  

  • 20. Donepezil for Down's syndrome.
    Kishnani PS; Spiridigliozzi GA; Heller JH; Sullivan JA; Doraiswamy PM; Krishnan KR
    Am J Psychiatry; 2001 Jan; 158(1):143. PubMed ID: 11136652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.